WallStreetZenWallStreetZen

NYSE: PATH
Uipath Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PATH

Based on 14 analysts offering 12 month price targets for Uipath Inc

Min Forecast
$14.00+12.36%
Avg Forecast
$16.00+28.41%
Max Forecast
$23.00+84.59%

Should I buy or sell PATH stock?

Based on 14 analysts offering ratings for Uipath Inc.

Hold
Strong Buy
1 analysts 7.14%
Buy
1 analysts 7.14%
Hold
11 analysts 78.57%
Sell
1 analysts 7.14%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their PATH stock forecasts and price targets.

PATH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-25
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-23
RBC Capital
Top 2%
99
HoldMaintains$15.00+20.39%2026-09-23
Needham
Bottom 1%
1
BuyReiterates$22.00+76.57%2026-09-23
Citigroup
Bottom 43%
43
Strong BuyInitiates Coverage On$23.00+84.59%2026-09-08
Barclays
Top 2%
99
HoldMaintains$17.00+36.44%2026-09-04
Mizuho
Bottom 6%
6
HoldMaintains$14.00+12.36%2026-09-04

1 of 2

Forecast return on equity

Is PATH forecast to generate an efficient return?

Company
28.91%
Industry
99.08%
Market
168.26%
PATH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PATH forecast to generate an efficient return on assets?

Company
19.38%
Industry
31.67%
PATH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PATH earnings per share forecast

What is PATH's earnings per share in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
$0.81+20.66%
Avg 2 year Forecast
$0.95+41.12%
Avg 3 year Forecast
$1.05+57.31%
PATH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PATH revenue forecast

What is PATH's revenue in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
$1.8B+6.63%
Avg 2 year Forecast
$2.0B+15.76%
Avg 3 year Forecast
$2.1B+22.03%
PATH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PATH earnings growth forecast

How is PATH forecast to perform vs Software - Infrastructure companies and vs the US market?

Company
11.9%
Industry
34.09%
Market
31.78%
PATH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PATH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PATH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PATH revenue growth forecast

How is PATH forecast to perform vs Software - Infrastructure companies and vs the US market?

Company
4.89%
Industry
19.58%
Market
13.9%
PATH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PATH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PATH vs Software Infrastructure Stocks

TickerPricePrice TargetUp/downsideConsensus
PATH$12.46$16.00+28.41%Hold
WEX$178.28$189.75+6.43%Buy
DOX$57.71$71.00+23.03%Buy
QLYS$172.43$165.42-4.07%Hold
NTSK$17.67$17.91+1.34%Strong Buy
View Top Software Infrastructure Stocks

Uipath Stock Forecast FAQ

Is Uipath Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: PATH) stock is to Hold PATH stock.

Out of 14 analysts, 1 (7.14%) are recommending PATH as a Strong Buy, 1 (7.14%) are recommending PATH as a Buy, 11 (78.57%) are recommending PATH as a Hold, 1 (7.14%) are recommending PATH as a Sell, and 0 (0%) are recommending PATH as a Strong Sell.

If you're new to stock investing, here's how to buy Uipath stock.

What is PATH's earnings growth forecast for 2027-2029?

(NYSE: PATH) Uipath's forecast annual earnings growth rate of 11.9% is not forecast to beat the US Software - Infrastructure industry's average forecast earnings growth rate of 34.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.78%.

Uipath's earnings in 2026 is $361,915,000.On average, 25 Wall Street analysts forecast PATH's earnings for 2027 to be $421,302,033, with the lowest PATH earnings forecast at $361,108,583, and the highest PATH earnings forecast at $471,176,605. On average, 25 Wall Street analysts forecast PATH's earnings for 2028 to be $492,752,439, with the lowest PATH earnings forecast at $385,081,732, and the highest PATH earnings forecast at $605,791,047.

In 2029, PATH is forecast to generate $549,297,801 in earnings, with the lowest earnings forecast at $449,444,425 and the highest earnings forecast at $631,171,316.

What is PATH's revenue growth forecast for 2027-2029?

(NYSE: PATH) Uipath's forecast annual revenue growth rate of 4.89% is not forecast to beat the US Software - Infrastructure industry's average forecast revenue growth rate of 19.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.

Uipath's revenue in 2026 is $1,720,858,000.On average, 25 Wall Street analysts forecast PATH's revenue for 2027 to be $956,320,175,515, with the lowest PATH revenue forecast at $908,373,877,887, and the highest PATH revenue forecast at $1,064,720,500,587. On average, 25 Wall Street analysts forecast PATH's revenue for 2028 to be $1,038,141,574,728, with the lowest PATH revenue forecast at $977,687,547,284, and the highest PATH revenue forecast at $1,162,176,562,070.

In 2029, PATH is forecast to generate $1,094,426,358,900 in revenue, with the lowest revenue forecast at $1,032,930,020,638 and the highest revenue forecast at $1,141,330,345,710.

What is PATH's forecast return on assets (ROA) for 2027-2029?

(NYSE: PATH) forecast ROA is 19.38%, which is lower than the forecast US Software - Infrastructure industry average of 31.67%.

What is PATH's Price Target?

According to 14 Wall Street analysts that have issued a 1 year PATH price target, the average PATH price target is $16.00, with the highest PATH stock price forecast at $23.00 and the lowest PATH stock price forecast at $14.00.

On average, Wall Street analysts predict that Uipath's share price could reach $16.00 by Sep 25, 2027. The average Uipath stock price prediction forecasts a potential upside of 28.41% from the current PATH share price of $12.46.

What is PATH's Earnings Per Share (EPS) forecast for 2027-2029?

(NYSE: PATH) Uipath's current Earnings Per Share (EPS) is $0.67. On average, analysts forecast that PATH's EPS will be $0.81 for 2027, with the lowest EPS forecast at $0.69, and the highest EPS forecast at $0.90. On average, analysts forecast that PATH's EPS will be $0.95 for 2028, with the lowest EPS forecast at $0.74, and the highest EPS forecast at $1.16. In 2029, PATH's EPS is forecast to hit $1.05 (min: $0.86, max: $1.21).

What is PATH's forecast return on equity (ROE) for 2027-2029?

(NYSE: PATH) forecast ROE is 28.91%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.